About NeuroCare Group
NeuroCare Group is a Healthcare company based in Munchen (Germany) founded in 2015 by Thomas Mechtersheimer. Noninvasive neurotechnology and personalized mental health platforms are provided. NeuroCare Group has raised $36.96 million across 3 funding rounds from investors including Impact Expansion, TVM Capital Healthcare and Palo Santo. NeuroCare Group has completed 1 acquisition, including Smart TMS. Its chief executive, as recorded, is Thomas Mechtersheimer. Its website neurocaregroup.com draws about 33 thousand monthly visits. NeuroCare Group offers products and services including TMS Systems, tDCS Devices, Neurofeedback Systems, EEG Systems, and Actigraphy Devices. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is neurocare group AG.
Company details
NeuroCare Group was founded in 2015 in Munich, Germany, within the neurotechnology and mental healthcare sector. Digital therapy systems are developed and supplied, incorporating clinical protocols and training for transcranial magnetic stimulation, neurofeedback, EEG, and neurological assessments. A software platform is utilized to assist clinicians with individualized patient care through device integration, workflow management, and therapy monitoring. Operations include deployment in company clinics and licensing to external practices.
- Total Equity Funding$36.96M (USD)
in 3 rounds
- Latest Funding Round$19.96M (USD), Series B
Feb 2025
- InvestorsImpact Expansion
& 6 more
- Investments & Acquisitions
Products & Services of NeuroCare Group
NeuroCare Group offers a comprehensive portfolio of products and services, including TMS Systems, tDCS Devices, Neurofeedback Systems, EEG Systems, and Actigraphy Devices.
Devices for transcranial magnetic stimulation in clinical research.
Stimulators for transcranial direct current stimulation treatments.
Systems for monitoring and training brain activity in therapy.
Electroencephalogram technology for mental health assessments.
Tools for assessing sleep hygiene in patient care.
Apps and channels of NeuroCare Group
its YouTube channel neurocare group has 1.11K subscribers and 30 videos.
Videos from NeuroCare Group
The most watched videos on NeuroCare Group's YouTube channel, neurocare group (1.11K subscribers). Click a video to play it here.
More on neurocare group.
Funding Insights of NeuroCare Group
NeuroCare Group has successfully raised a total of $36.96M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $19.96 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.96M
- Total Rounds 3
- Last Round Series B — $19.96M
- Investors Count 7
All 3 funding rounds of NeuroCare Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $19.96M | Series B | – | – | |
| Apr 2024 | $17M | Series A | – | – | |
| Sep 2021 | Seed | – | Palo Santo |
7 investors in total: 7 institutional.
Investors in NeuroCare Group
NeuroCare Group has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Impact Expansion, TVM Capital Healthcare and Palo Santo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| impact-expansion.com | ||||
Healthcare growth capital investments are made in transformational companies. | tvmcapitalhealthcare.com | Singapore, Singapore | ||
Limited information is provided about Palo Santo's activities. | palosanto.vc | |||
Venture capital firm backed by Christian Angermayer | apeiron-investments.com | Sliema, Malta | ||
Early-stage investments are provided in mental health and brain health sectors. | remind.vc | London, United Kingdom | ||
Venture capital and private equity investments are managed by bm|t. | bm-t.de | Erfurt, Germany | ||
Capital is invested in life science innovations for healthcare transformation. | tvm-capital.com | Munich, Germany |
Investor details for NeuroCare Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NeuroCare Group
16 people are tracked at NeuroCare Group (9 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Thomas Mechtersheimer | Founder & CEO | Leadership |
Philip McDaniel | National Account Director | Leadership |
Brandon Miller | Director Of Operations | Leadership |
Tom Mechtersheimer | Founder & CEO Neurocare Group AG | Leadership |
Peter Obstoj | Operations Director | Leadership |
Anthony Deeb | Sales Director, Neurocare Group | Leadership |
Brett Scoccia | Vice President Of Sales And Business Development | Leadership |
Paul Girardi | Regional Sales Director East | Leadership |
Tariq El-Titi | Senior Vice President - MENA | Leadership |
Claudia Caballero | Psychologist | Team |
Miriam Mina | Senior Clinical Training Manager | Team |
Gunner Womer | Territory Manager | Team |
Trevor Brown | Neuroscientist, Global Academy Manager At Neurocare Group | Team |
Natalie Giroux | Central Territory Manager | Team |
Dorothee Schlueter | Mitarbeiterin | Team |
Marleen Stam | Psychologist NIP And Global Trainer, Rtms & Neurofeedback Specialist At Neurocare Group | Team |
Complete people profiles for NeuroCare Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NeuroCare Group
NeuroCare Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Smart TMS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Smart TMS is recognized as a leading provider of Transcranial Magnetic Stimulation therapy in the UK and Ireland. | smarttms.co.uk | Cirencester, United Kingdom | 2015 | Jul 2024 | •••• |
Complete acquisition details for NeuroCare Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NeuroCare Group
4 dated milestones of NeuroCare Group across 10 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroCare Group is founded.
- Funding First funding round.
- Acquisition Acquires Smart TMS.
- Funding Latest funding round, Series B, of $20.0M.
Web traffic of NeuroCare Group
The website of NeuroCare Group (neurocaregroup.com) receives about 33.5K visits a month and ranks #658,258 among all websites worldwide, #1,088 in Mental Health.
- Monthly visits33.5K
▲ 0.7% vs previous month
- Unique visitors12.2K
per month
- Global rank#658,258
among all websites
- Category rank#1,088
Health · Mental Health
- Bounce rate39%
- Pages per visit4.7
- Average visit2 min 09 sec
- DevicesDesktop 44% · Mobile 56%
Websites whose visitors overlap most with NeuroCare Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kantoko.com.au | kantoko.com.au | 100% | #839,887 | – | |
someone.health | someone.health | 98% | #298,859 | – | |
fluenceclinic.com | fluenceclinic.com | 97% | #782,977 | – | |
myadhdcentre.com.au | myadhdcentre.com.au | 96% | #7,883,828 | – | |
| yourhealthinmind.org | 96% | 46.1K | #595,992 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for NeuroCare Group
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurocare Group
Complete news archive for NeuroCare Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuroCare Group
NeuroCare Group was founded in 2015 and raised its 1st funding round 6 years after it was founded.
NeuroCare Group is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Thomas Mechtersheimer is the CEO of NeuroCare Group, as recorded in our data. They have also founded this company.
NeuroCare Group is a funded company, having raised a total of $36.96M across 3 funding rounds to date.
NeuroCare Group was founded in 2015 in Munich, Germany, within the neurotechnology and mental healthcare sector. Digital therapy systems are developed and supplied, incorporating clinical protocols and training for transcranial magnetic stimulation, neurofeedback, EEG, and neurological assessments. A software platform is utilized to assist clinicians with individualized patient care through device integration, workflow management, and therapy monitoring. Operations include deployment in company clinics and licensing to external practices.
NeuroCare Group offers TMS Systems, tDCS Devices, Neurofeedback Systems, EEG Systems, and Actigraphy Devices.
NeuroCare Group has made 1 acquisition, including Smart TMS.
NeuroCare Group has 7 investors. Key investors include Impact Expansion, TVM Capital Healthcare, Palo Santo, Apeiron Investment Group, and re.Mind Capital.
NeuroCare Group operates through Neurocare Group Ag.